Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ctdna-dynamics-predict-treatment-response-early-her2-breast-2025a1000z0q?src=rss
Author :
Publish date : 2025-12-15 04:21:00
Copyright for syndicated content belongs to the linked Source.